The pharmacy benefits manager agreed to pay $5 million to settle charges by the Federal Trade Commission that the company had misrepresented the price of certain prescription drugs in one of its Medicare drug plans.
By REED ABELSON and NATASHA SINGER, New York Times
Thu, 01/12/2012 - 9:59am
The pharmacy benefits manager agreed to pay $5 million to settle charges by the Federal Trade Commission that the company had misrepresented the price of certain prescription drugs in one of its Medicare drug plans.